LINC02502

Across TCGA pan-cancer cohorts, LINC02502 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02502 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher LINC02502 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02502 expression acts as an unfavorable survival marker, although some lineages such as LUSC and PAAD show a favorable association.

DLBC, LUSC, and KIRP are the cancer types where LINC02502 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.183	0.952	<.001	70	view →
LUSC	OS	Median	II,III,IV	0.809	0.669	.001	53	view →
KIRP	DFS	Tertile	All	0.599	0.885	<.001	51	view →
COAD	DFS	Tertile	All	0.170	0.520	.002	48	view →
PAAD	DFS	Tertile	All	0.648	0.267	<.001	45	view →
LUAD	DFS	Tertile	IV	0.429	0.749	.012	39	view →
LGG	OS	Quartile	All	0.710	0.850	<.001	36	view →
STAD	OS	Tertile	IV	0.130	0.644	<.001	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
SKCM	DFS	Tertile	III,IV	0.752	0.423	.002	29	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	18	view →
HNSC	DFS	Median	All	0.269	0.417	.012	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02502–DLBC (OS)

Open the DLBC breakdown →